Search Results 151-160 of 16876 for Lou Gehrig's disease

  1. A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS).

  2. Neurosciences Clinical Trials - Medical Professionals

    HEALEY ALS Platform Trial. Rochester, Minn ... ALS. Submandibular Gland ... Disease Progression of Parkinson's Disease and REM Sleep Behavior Disorder.

  3. Abobotulinumtoxina (intramuscular route) - Side effects & uses - Mayo Clinic

    Other Medical Problems · Amyotrophic lateral sclerosis (Lou Gehrig's disease) or · Dermatochalasis (a skin problem) or · Lambert-Eaton syndrome (nerve-muscle ...

  4. A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis - Mayo Clinic

    ... (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  5. Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS - Mayo Clinic

    ... (ALS), based on the time from the randomization date in Study MT-1186-A02 to at least a 12-point decrease in Revised ALS ... disease, and previous treatments or ...

  6. Mayo Clinic Q and A: Understanding binge eating disorder

    Helping Others Heal: Hoping her story will lift others struggling with eating disorders published 10/31/18. Sandra's story of living with Lou Gehrig's disease.

  7. Neurology - Clinical trials

    Search for a disease or condition . Type 3 or ... syndrome (POTS). ... ALS we aim to eventually identify immune therapies that may provide benefit in ALS.

  8. Neurosciences News - Medical Professionals - Mayo Clinic

    Timely diagnosis promotes optimal management of disease progression. Aug. 29, 2025. Research finds AI model can predict ALS. Mayo Clinic scientists used data- ...

  9. A Biospecimen Repository for Neurodegenerative Disease Research in Cooperation with the National Cell Repository for Alzheimer Disease - Mayo Clinic

    ... ALS, ALS-FTD or similar neurodegenerative motor neuron disorders, and are participating in NINDS funded research projects in the Mayo Clinic ALS Center.

  10. Rimabotulinumtoxinb (intramuscular route) - Side effects & uses - Mayo Clinic

    ... problems, especially: Amyotrophic lateral sclerosis (Lou Gehrig's disease) or; Lambert-Eaton syndrome (nerve-muscle disorder) or; Motor neuropathy (muscle or ...